Male Reproductive System Carcinoma — Trials

Male Reproductive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 451
Recruiting: 240
Ph III recruiting: 20
Growth YoY: +1.3%
Industry share: 25%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (190)

clinicaltrialsPublishedShowing 151–157 of 157 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01981707	F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer(PRECHOL)	terminated	Phase 2 / Phase 3	12	University Hospital, GrenobleOTHER	1	Apr 28, 2016	clinicaltrials
NCT02024685	Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial	terminated	N/A	76	Case Comprehensive Cancer CenterOTHER	1	Nov 10, 2015	clinicaltrials